Reuters logo
BRIEF-Genentech says phase III study shows Actemra maintained steroid-free remission in people with giant cell arteritis
June 6, 2016 / 5:01 PM / in 2 years

BRIEF-Genentech says phase III study shows Actemra maintained steroid-free remission in people with giant cell arteritis

June 6 (Reuters) -

* Genentech says phase III study Shows Actemra maintained steroid free remission in people with giant cell arteritis

* Genentech says study met its primary and key secondary endpoints Source text for Eikon: (Bengaluru Newsroom; +1 646 223 8780; )

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below